Literature DB >> 2776370

Comparative study on Lewis lung tumour lines with 'low' and 'high' metastatic capacity. III. Glycosaminoglycan synthesis, transport and degradation in cell lines.

G Pogány1, E Moczar, A Jeney, J Timár, F Timár, K Ditrói, K Lapis.   

Abstract

The glycosaminoglycans (GAGs) of low (LM) and highly metastatic (HM) cell lines of the Lewis lung tumour (3LL) were compared using [3H]glucosamine labelling techniques. The GAGs isolated from nuclei, cytoplasm, pericellular fractions and medium were analysed by cellulose acetate electrophoresis and by digestion with specific enzymes, and the following conclusions were drawn. 1. Increased cellular uptake and incorporation of [3H]glucosamine into glycoconjugates of the cytoplasm was a typical feature of the highly metastatic cell line after a 48-h labelling. However, there was no elevated radioactivity in glycolipids. 2. Radioactivity of the purified GAGs was two and three times higher in nuclear and cytoplasmic fractions of HM cells than in those of LM cells. There was much less difference between the two cell lines in the pericellular fractions. 3. A definite change from chondroitin sulphate to dermatan sulphate dominancy was recorded in each GAG fraction. Higher heparan sulphate labelling was observed in the cytoplasmic and pericellular GAGs of HM cultures. 4. In the post-labelling period about three times more GAG was present in the extracellular compartment of the HM cultures compared with the LM cultures. 5. In the LM cultures the total GAG-associated radioactivity decreased by 73 per cent in the 48-h chase period whereas in the HM cultures it decreased by only 30 per cent. This indicates a higher rate of GAG degradation in the LM cultures.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2776370     DOI: 10.1007/BF01753676

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  27 in total

1.  Studies in histochemistry. I. Determination of nucleic acids in microgram amounts of tissue.

Authors:  J F SCOTT; A P FRACCASTORO; E B TAFT
Journal:  J Histochem Cytochem       Date:  1956-01       Impact factor: 2.479

2.  Characterization of cellular and extracellular plasma membrane vesicles from a low metastatic lymphoma (Eb) and its high metastatic variant (ESb): inhibitory capacity in cell-cell interaction systems.

Authors:  V Schirrmacher; D Barz
Journal:  Biochim Biophys Acta       Date:  1986-08-21

3.  The estimation of acid glycosaminoglycan-Alcian blue complexes eluted from electrophoretic strips.

Authors:  D J Newton; J E Scott; P Whiteman
Journal:  Anal Biochem       Date:  1974-11       Impact factor: 3.365

4.  Cell surface glycolipids and glycoproteins in malignant transformation.

Authors:  G Yogeeswaran
Journal:  Adv Cancer Res       Date:  1983       Impact factor: 6.242

5.  Comparative study on Lewis lung tumor lines with 'low' and 'high' metastatic capacity. II. Cytochemical and biochemical evidence for differences in glycosaminoglycans.

Authors:  J Timár; E Móczar; F Timár; K Pál; L Kopper; K Lapis; A Jeney
Journal:  Clin Exp Metastasis       Date:  1987 Jan-Mar       Impact factor: 5.150

6.  Heparin binds endothelial cell growth factor, the principal endothelial cell mitogen in bovine brain.

Authors:  T Maciag; T Mehlman; R Friesel; A B Schreiber
Journal:  Science       Date:  1984-08-31       Impact factor: 47.728

Review 7.  Cell surface molecules and tumor metastasis. Regulation of metastatic phenotypic diversity.

Authors:  G L Nicolson
Journal:  Exp Cell Res       Date:  1984-01       Impact factor: 3.905

8.  Altered expression of glycosaminoglycans in metastatic 13762NF rat mamma adenocarcinoma cells.

Authors:  P A Steck; P H Cheong; M Nakajima; W K Yung; R P Moser; G L Nicolson
Journal:  Biochemistry       Date:  1987-02-24       Impact factor: 3.162

9.  Glycosaminoglycan synthesis by subpopulations of epithelial cells from a mammary adenocarcinoma.

Authors:  J C Angello; K G Danielson; L W Anderson; H L Hosick
Journal:  Cancer Res       Date:  1982-06       Impact factor: 12.701

10.  The functions of the heparan sulphate proteoglycans.

Authors:  L A Fransson; I Carlstedt; L Cöster; A Malmström
Journal:  Ciba Found Symp       Date:  1986
View more
  1 in total

1.  Role of Proteoglycans in Tumor Progression.

Authors:  József Timár; András Jeney; László Kopper
Journal:  Pathol Oncol Res       Date:  1995       Impact factor: 3.201

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.